{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T21:57:28Z","timestamp":1766267848237,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.cmi.2023.05.021","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T17:15:48Z","timestamp":1684862148000},"page":"1237-1240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Which trial do we need? A collaborative platform trial for cutaneous leishmaniasis amongst international travellers"],"prefix":"10.1016","volume":"29","author":[{"given":"Martin","family":"Vandeputte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"van Henten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"van Griensven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Bottieau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2023.05.021_bib1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"year":"2015","series-title":"WHO report on global surveillance of epidemic-prone infectious diseases \u2013 leishmaniasis","key":"10.1016\/j.cmi.2023.05.021_bib2"},{"key":"10.1016\/j.cmi.2023.05.021_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taz055","article-title":"Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel surveillance network analysis","volume":"26","author":"Boggild","year":"2019","journal-title":"J\u00a0Travel Med"},{"key":"10.1016\/j.cmi.2023.05.021_bib4","doi-asserted-by":"crossref","first-page":"e1032","DOI":"10.1016\/j.ijid.2010.06.019","article-title":"Leishmaniasis, an emerging infection in travelers","volume":"14","author":"Pavli","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.021_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009863","article-title":"Clinical diversity and treatment results in tegumentary leishmaniasis: a European clinical report in 459 patients","volume":"15","author":"Guery","year":"2021","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2023.05.021_bib6","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.4.2002028","article-title":"Surveillance of leishmaniasis cases from 15 European centres,\u00a02014\u00a0to\u00a02019: a retrospective analysis","volume":"27","author":"Van der Auwera","year":"2022","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.cmi.2023.05.021_bib7","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1093\/cid\/ciw670","article-title":"Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the infectious diseases society of America (IDSA) and the American society of tropical medicine and hygiene (ASTMH)","volume":"63","author":"Aronson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.021_bib8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jtm.12089","article-title":"LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014","volume":"21","author":"Blum","year":"2014","journal-title":"J\u00a0Travel Med"},{"key":"10.1016\/j.cmi.2023.05.021_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002832","article-title":"Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide","volume":"8","author":"Hodiamont","year":"2014","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2023.05.021_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101885","article-title":"Epidemiology, clinical pattern and impact of species-specific molecular diagnosis on management of leishmaniasis in Belgium, 2010\u20132018: a retrospective study","volume":"38","author":"Vandeputte","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.021_bib11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/cid\/cit269","article-title":"Travelers with cutaneous leishmaniasis cured without systemic therapy","volume":"57","author":"Morizot","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.05.021_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.inhe.2012.06.004","article-title":"Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis","volume":"4","author":"Blum","year":"2012","journal-title":"Int Health"},{"key":"10.1016\/j.cmi.2023.05.021_bib13","article-title":"Interventions for Old World cutaneous leishmaniasis","volume":"11","author":"Heras-Mosteiro","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2023.05.021_bib14","article-title":"Interventions for American cutaneous and mucocutaneous leishmaniasis (Review) 2020","volume":"8","author":"Pinart","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2023.05.021_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002130","article-title":"Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis","volume":"7","author":"Olliaro","year":"2013","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2023.05.021_bib16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/tmi.13048","article-title":"Eligibility criteria and outcome measures adopted in clinical trials of treatments of cutaneous leishmaniasis: systematic literature review covering the period 1991-2015","volume":"23","author":"L\u00f3pez-Carvajal","year":"2018","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.cmi.2023.05.021_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006141","article-title":"Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation","volume":"12","author":"Olliaro","year":"2018","journal-title":"PLOS Negl Trop Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23002458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23002458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:34:13Z","timestamp":1761118453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X23002458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1198743X23002458"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2023.05.021","relation":{},"ISSN":["1198-743X"],"issn-type":[{"type":"print","value":"1198-743X"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Which trial do we need? A collaborative platform trial for cutaneous leishmaniasis amongst international travellers","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2023.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}